Characterization of differential antibody production against hepatitis C virus in different HCV infection status

BACKGROUND: The Centers for Disease Control and Prevention (CDC) issued an update on hepatitis C virus (HCV) testing approach, in which it omitted the use of recombinant immunoblot assay (RIBA) in the diagnostic algorithm and recommended that future studies are needed to evaluate the performance of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Virol J
Autori principali: Rafik, Mona, Bakr, Salwa, Soliman, Dina, Mohammed, Nesrine, Ragab, Dina, ElHady, Walid Abd, Samir, Nancy
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928299/
https://ncbi.nlm.nih.gov/pubmed/27357382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-016-0572-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi